CoChat

Novel strategies for the treatment of grass pollen-induced allergic rhinitis

Larsson, Olivia, Hellkvist, Laila, Peterson-Westin, Ulla, Cardell, Lars Olaf · 2016 · Expert Opinion on Biological Therapy

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Introduction Allergic rhinitis (AR) affects over 20% of the population of Europe and the United States. Allergen immunotherapy (AIT) is currently the only form of treatment that affects symptoms and modifies the progression of disease. Established forms of AIT include subcutaneous (SCIT) and sublingual (SLIT) immunotherapy and are widely effective, yet only 2-9% of eligible patients undergo therapy, likely due to the long duration of treatment. As a result, novel, faster forms of AIT are currently under development. Areas covered This article provides an overview of AR and summarises the efficacy and mechanisms of established forms of AIT, highlighting the current drawbacks. We discuss novel strategies of AIT that have been developed in an attempt to tackle these limitations, including epicutaneous, intradermal and intralymphatic immunotherapy (ILIT), focusing on ILIT, the treatment that has been most comprehensively assessed. Expert opinion Current strategies to treat AR suffer from a poor safety profile and, importantly, lack of adherence. ILIT is a faster and safer form of AIT, with a treatment regime of only 12 weeks. Further validation is required, but ILIT, with its short and comparatively inexpensive protocol, has the potential to offer disease-modifying therapy to a larger number of patients.

Overview

Integrity signals

Registry

Crossref · 10.1080/14712598.2016.1190829

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 70 references

Research works printed but not linked: 2

  1. Calderon MA, 2007, Cochrane Database Syst Rev, 1, CD001936
  2. Mansson A, 2010, J Investig Allergol Clin Immunol, 20, 476

Cited by

See all 17

Metadata

Authors
Larsson, O., Hellkvist, L., Peterson-Westin, U., & Cardell, L. O.
Affiliations
  • Karolinska Institutet (SE)
  • Karolinska University Hospital (SE)
Corresponding author
Cardell, Lars Olaf
Venue
Expert Opinion on Biological Therapy
Published
2016-06-09
Volume
16
Issue
9
Pages
1143-1150
ISSN
  • 1471-2598 (ISSN-L)
  • 1744-7682
OpenAlex
W2418754072
Cited by
16
References
70
Citations by year
2026: 1 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 1
FWCI
0.25
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Biological Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
allergic rhinitis, grass pollen allergy, allergen immunotherapy, intralymphatic immunotherapy, epicutaneous immunotherapy, intradermal immunotherapy, sublingual immunotherapy, subcutaneous immunotherapy, medication adherence, immunotherapy safety, disease-modifying therapy
MeSH terms
Allergens, Animals, Desensitization, Immunologic, Europe, Poaceae, Humans, Injections, Intralymphatic, Pollen, Time Factors, United States, Treatment Outcome, Sublingual Immunotherapy, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel strategies for the treatment of grass pollen-induced allergic rhinitis. https://app.cochat.ai/papers/10.1080/14712598.2016.1190829
The paper
Larsson, O., Hellkvist, L., Peterson-Westin, U., & Cardell, L. O. (2016). Novel strategies for the treatment of grass pollen-induced allergic rhinitis. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2016.1190829

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.